Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALLKristina Müller, Denis M. Schewe, Monika Brüggemann et al.|Blood|2022Cited by 47
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Denis M. Schewe, Julia Heymann et al.|Blood Advances|2022Cited by 20
Venetoclax Enhances the Efficacy of Therapeutic Antibodies in B-Cell MalignanciesFotini Vogiatzi, Denis M. Schewe, Julia Heymann et al.|Blood|2018Cited by 0
Co-Targeting of CD38 and CD47 in T Cell Acute Lymphoblastic LeukemiaFotini Vogiatzi, Denis M. Schewe, Kristina Müller et al.|Blood|2020Cited by 0